Clinical Trial: A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07082114) titled 'A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus' on July 10.

Brief Summary: This is a multicenter, randomized, double-blind, active-controlled, parallel-group study, which aims to provide data on the efficacy and safety of HDM1002 tablets compared with dapagliflozin in adults with type 2 diabetes mellitus (T2DM) inadequately controlled on metformin.

Study Start Date: July 14

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes

Intervention: DRUG: HDM1002 100 mg

HDM1002 tablets, 100 mg once daily, 52 weeks

DRUG: HDM1002 200 mg

HDM1002 tablets, 200 mg once daily, 52 ...